Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.

Current HIV research - 1 Jan 2022

Gao Peijie, Yu Fengting, Yang Xiaozhen, Li Dan, Shi Yalun, Wang Yan, Zhang Fujie

Abstract excerpt

BACKGROUND: HIV drug resistance poses a major challenge for anti-retroviral treatment (ART) and the prevention and control of HIV epidemic. OBJECTIVE: The study aims to establish a novel in-house assay with high efficiency, named AP inhouse method, that would be suitable for HIV-1 drug resistance detection in China. METHODS: An in-house HIV-1 genotyping method was used to sequence the partial pol gene from 60...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to China
Share to Drug Resistance, Viral
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Seropositivity

Share to Phylogeny

Share to Reverse Transcriptase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 34515004
DOI: 10.2174/1570162X19666210910144433
PMCID: PMC9127726

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.PMID 34515004Read ↗

Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.Semantic proximity Read ↗

[The study of an in-house method for drug resistance genotyping testing on HIV-1 strains prevailing in China].Semantic proximity Read ↗

Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.Semantic proximity Read ↗

Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.Semantic proximity Read ↗

Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, ChinaSemantic proximity Read ↗

Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017-2019).Semantic proximity Read ↗

Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.Semantic proximity Read ↗

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.Semantic proximity Read ↗

HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016-2023).Semantic proximity Read ↗

[Survey of HIV-1 drug resistance threshold in Shandong Province in 2013-2015].Semantic proximity Read ↗

Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017.Semantic proximity Read ↗

Brief communication: characteristics of primary drug resistance in newly diagnosed HIV-infected individuals in Ganzhou, China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.